- ►annals.org [PDF] A Jain, A Atreja, CM Harris, M Lehmann, J … - Annals of internal medicine, 2005 - Am Coll Physicians Responding to the Rofecoxib Withdrawal Crisis: A New Model for ... Notifying
Patients at Risk and Their Health Care Providers ... Anil Jain, MD; Ashish
Atreja, MD, MPH; C. Martin Harris, MD, MBA; Meghan Lehmann, PharmD; Jon ... Cited by 17 - Related articles - All 5 versions
T Nashville - Ann Intern Med, 2005 - atreja.info Responding to the Rofecoxib Withdrawal Crisis: A New Model for ... Notifying
Patients at Risk and Their Health Care Providers ... Anil Jain, MD; Ashish
Atreja, MD, MPH; C. Martin Harris, MD, MBA; Meghan Lehmann, PharmD; Jon ... Related articles - View as HTML
R Badgett, C Mulrow - Annals of internal medicine, 2005 - Am Coll Physicians In this issue, Jain and colleagues (1) display the power of information
technology (IT) to facilitate communication about important health care
information. The information was Merck's withdrawal of rofecoxib at 9:00 am ... Cited by 8 - Related articles - All 4 versions
[CITATION] Cardiovascular risk of selective Cox-2 inhibitors: Facts or fiction
TC Wenzel, CR Manning, JG Chandler, DF … - The Journal of heart valve disease, 1999 - ncbi.nlm.nih.gov BACKGROUND AND AIM OF THE STUDY: Multiple reports of convexo-concave valve
outlet strut fractures have focused on the welds, often implicating putative
defects of uncertain character and significance. This study differs from ... Cited by 2 - Related articles - BL Direct - All 2 versions
HA Lima, RA RISK, RA LUTES, WE HICKS, … - American journal of health-system pharmacy, 1995 - cat.inist.fr WANTED: TIMELY RECEIPT OF DRUG-RECALL INFORMATION. HA LIMA, RA RISK, RA LUTES,
WE HICKS, SA CANTRELL American journal of health-system ... Cited by 3 - Related articles - All 3 versions
